Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Peptides. 2012 Jun 9;36(2):168–175. doi: 10.1016/j.peptides.2012.05.021

Fig. 7.

Fig. 7

A-L. %Inj/g of I-PACAP without CD, I-PACAP with α-CD, and I-PACAP with Hydro-β-CD in olfactory bulb (A: Olf), occipital cortex (B: OC), striatum (C: St), frontal cortex (D: FC), hypothalamus (E: Hyth), thalamus (F: Th), hippocampus (G: Hip), parietal cortex (H: PC), cerebellum (I: Cb), midbrain (J: Mb), pons-medulla (K: PM) and whole brain (L: WBr) at 60 min after i.n. administration. ANOVAs showed difference for Olf, OC, St, FC, Hyth, Th, Hip, PC, Cb, Mb, PM and WBr. Newman-Keuls Multiple Comparison Test showed Olf, OC, St, FC, Hyth, Th, Hip, PC, Cb, Mb, PM, and WBr in I-PACAP without CD, I-PACAP with α-CD, and IPACAP with Hydro-β-CD (* p < 0.05, ** p < 0.01, *** p < 0.001). n = 6 - 11 mice/groups.